A. Kaya Et Al. , "Ibrutinib-Associated Leukocytoclastic Vasculitis in a Patient with Chronic Lymphocytic Leukemia," Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.41, no.1, pp.57-58, 2024
Kaya, A. Et Al. 2024. Ibrutinib-Associated Leukocytoclastic Vasculitis in a Patient with Chronic Lymphocytic Leukemia. Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.41, no.1 , 57-58.
Kaya, A., Aras, İ., Özkan Kurtgöz, P., & Çakıroğlu, U., (2024). Ibrutinib-Associated Leukocytoclastic Vasculitis in a Patient with Chronic Lymphocytic Leukemia. Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.41, no.1, 57-58.
Kaya, Ayşe Et Al. "Ibrutinib-Associated Leukocytoclastic Vasculitis in a Patient with Chronic Lymphocytic Leukemia," Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.41, no.1, 57-58, 2024
Kaya, Ayşe Et Al. "Ibrutinib-Associated Leukocytoclastic Vasculitis in a Patient with Chronic Lymphocytic Leukemia." Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.41, no.1, pp.57-58, 2024
Kaya, A. Et Al. (2024) . "Ibrutinib-Associated Leukocytoclastic Vasculitis in a Patient with Chronic Lymphocytic Leukemia." Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.41, no.1, pp.57-58.
@article{article, author={Ayşe Kaya Et Al. }, title={Ibrutinib-Associated Leukocytoclastic Vasculitis in a Patient with Chronic Lymphocytic Leukemia}, journal={Turkish journal of haematology : official journal of Turkish Society of Haematology}, year=2024, pages={57-58} }